DB16280InvestigationalSmall molecule
Pegcantratinib is under investigation in clinical trial NCT03448081 (Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene).
- Mechanism
- Curator reviewed
Pharmacologically active on High affinity nerve growth factor receptor
- Code names
- CT-327 · SNA-120
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Pegcantratinib, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account